<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">nefr</journal-id><journal-title-group><journal-title xml:lang="ru">Нефрология</journal-title><trans-title-group xml:lang="en"><trans-title>Nephrology (Saint-Petersburg)</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-6274</issn><issn pub-type="epub">2541-9439</issn><publisher><publisher-name>Pavlov First Saint-Petersburg State Medical University</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.24884/1561-6274-2005-9-4-67-74</article-id><article-id custom-type="elpub" pub-id-type="custom">nefr-724</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group></article-categories><title-group><article-title>ГИПЕРГОМОЦИСТЕИНЕМИЯ УСУГУБЛЯЕТ ПОВРЕЖДЕНИЯ НЕФРОНА ПРИ ЭКСПЕРИМЕНТАЛЬНОЙ ХРОНИЧЕСКОЙ ПОЧЕЧНОЙ НЕДОСТАТОЧНОСТИ</article-title><trans-title-group xml:lang="en"><trans-title>HYPERHOMOCYSTEINEMIA EXACERBATES THE NEPHRON INJURIES INDUCED BY EXPERIMENTAL KIDNEY FAILURE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Смирнов</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Smirnov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Добронравов</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Dobronravov</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Неворотин</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Nevorotin</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Хохлов</surname><given-names>С. Е.</given-names></name><name name-style="western" xml:lang="en"><surname>Khokhlov</surname><given-names>S. E.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сиповский</surname><given-names>В. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Sipovsky</surname><given-names>V. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Барабанова</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Barabanova</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чефу</surname><given-names>С. Г.</given-names></name><name name-style="western" xml:lang="en"><surname>Chefu</surname><given-names>S. G.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жлоба</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhloba</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Блашко</surname><given-names>Э. Л.</given-names></name><name name-style="western" xml:lang="en"><surname>Blashko</surname><given-names>E. L.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Научно-исследовательский центр, кафедра патологической физилогии</p></bio><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff xml:lang="ru" id="aff-1"><institution>Научно-исследовательский институт нефрологии, Cанкт-Петербургский государственный медицинский университет имени акад. И.П. Павлова</institution><country>Russian Federation</country></aff><pub-date pub-type="collection"><year>2005</year></pub-date><pub-date pub-type="epub"><day>10</day><month>04</month><year>2005</year></pub-date><volume>9</volume><issue>4</issue><fpage>67</fpage><lpage>74</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Смирнов А.В., Добронравов В.А., Неворотин А.И., Хохлов С.Е., Сиповский В.Г., Барабанова В.В., Чефу С.Г., Жлоба А.А., Блашко Э.Л., 2005</copyright-statement><copyright-year>2005</copyright-year><copyright-holder xml:lang="ru">Смирнов А.В., Добронравов В.А., Неворотин А.И., Хохлов С.Е., Сиповский В.Г., Барабанова В.В., Чефу С.Г., Жлоба А.А., Блашко Э.Л.</copyright-holder><copyright-holder xml:lang="en">Smirnov A.V., Dobronravov V.A., Nevorotin A.I., Khokhlov S.E., Sipovsky V.G., Barabanova V.V., Chefu S.G., Zhloba A.A., Blashko E.L.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.nephrolog.ru/jour/article/view/724">https://journal.nephrolog.ru/jour/article/view/724</self-uri><abstract><p>ЦЕЛЬ ИССЛЕДОВАНИЯ – оценить возможный вклад гомоцистеина в развитие повреждений клубочков и проксимальных канальцев (ПК) в условиях экспериментальной хронической почечной недостаточности (ПН). МАТЕРИАЛ И МЕТОДЫ. Использовали крыс линии Вистар, которые были подвергнуты субтотальной нефрэктомии. Экспериментальной группе животных (n=11) после операции вводили гомоцистеин (ГЦ) в дозе 13,4 мг/кг внутримышечно. В качестве контрольной группы использовали нефрэктомированных животных без последующего введения ГЦ (n=10). В обеих группах определяли концентрацию общего ГЦ, креатинина, мочевины плазмы крови, а также суточный диурез, концентрацию альбумина и креатинина мочи с последующим расчетом отношения альбумин/креатинин (ACR), концентрационного индекса (Ucr/Pcr) и клиренса креатинина (Ccr). Проводили светооптическое и электронномикроскопическое исследование почек. РЕЗУЛЬТАТЫ. Общий ГЦ плазмы крови составил 5,0±0,7 μ моль/л и 7,7±1,5 μ моль/л в контрольной и экспериментальной группах соответственно (p &lt; 0.005). У экспериментальных животных в сравнении с контрольными были выше значения logACR на 100 г массы (2,12±0,52 vs 1,43±0,32 мг/г, p &lt;0 .025), креатинина плазмы (79,0±13,9 vs 56,3±8,0 μ моль/л, p &lt; 0.001) и ниже Ccr (0,20±0,07 vs 0,46±0,08 мл/мин, p &lt; 0.005) и Ucr/Pcr (53,2±25,9 vs 123,3±25,7, p &lt;0 .005). Морфологически в контрольной группе крыс выявлены умеренная мезангиальная пролиферация и адгезия лейкоцитов к эндотелию капилляров клубочков наряду с выраженным нарастанием количества структур, отражающих эндоцитоз, включая большие апикальные вакуоли в клетках ПК. Назначение ГЦ приводило к усугублению описанных повреждений в обоих отделах нефрона, а также к депозиции фибрина в просвете капилляров и выраженной дезорганизации базальной цитоплазмы клеток ПК. ЗАКЛЮЧЕНИЕ. Результаты светооптического и субмикроскопического анализа в сочетании с биохимическими данными рассматривают ся как прямое свидетельство дополнительного повреждающего воздействия ГГЦ на основные клеточные популяции не фрона в условиях экспериментальной ПН.</p></abstract><trans-abstract xml:lang="en"><p>THE AIM of the investigation was to evaluate a possible impact of homocysteine (HCy) on the glomerular and proximal tubule cell injury in the remnant kidney model (RKM). MATERIAL AND METHODS. An experimental group of adult male albino Wistar rats underwent subtotal nephrectomy followed by daily administration of HCy (i.m., 13.4 mg/kg) for three weeks (n=11). Nephrectomized rats not given HCy were used as a control group (n=11). Routine blood and urine functional tests as well as light and electron microscopic examinations of the kidney samples were used to compare urine albumincreatinine ratio (ACR), creatinine clearance (Ccr) and cell alterations in RKM alone and those with a combination of RKM and superimposed hyperhomocysteinemia. RESULTS. Total plasma HCy was 5.0±0.7 and 7.7±1.5 in control and experimental animals respectively (p&lt; 0.005). In the experimental group an increased logACR per 100 g of body mass (2.12±0.52 vs 1.43±0.32 mg/g, p&lt;0.025) and plasma creatinine concentration (79.0±13.9 vs 56.3±8.0, p&lt; 0.001) and decreased Ccr (0.20±0.7 vs 0.46±0.08 ml/min, p&lt;0.005) and Ucr/Pcr (53.2±25.9 vs 123±25.7, p&lt;0.005) were observed as compared to the control group. Moderate mesangial cell proliferation and local leukocyte adhesion to the endothelial lining in the glomeruli, with a pronounced increase of the amount of endocytosislabeling structures, large apical vacuoles included, in the proximal tubule cells, were registered in the kidney parenchyma of the RKM rats. Administration of HCy apparently aggravated the above mentioned alterations in both nephron compartments and also resulted in fibrin deposition within the glomerular capillaries and extensive disorganization of the basal cytoplasm in the proximal tubule cells. CONCLUSION. Both light and electron microscopic data reinforced by the appropriate biochemical findings are considered as a direct evidence of the additional deleterious effects of HCy on the major cell populations of the nephron under conditions of experimental renal failure.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>экспериментальная почечная недостаточность</kwd><kwd>гипергомоцистеинемия</kwd><kwd>электронная микроскопия</kwd><kwd>канальцы</kwd><kwd>клубочки</kwd></kwd-group><kwd-group xml:lang="en"><kwd>experimental renal failure</kwd><kwd>hyperhomocysteinemia</kwd><kwd>kidney cell disorganization</kwd><kwd>electron microscopy</kwd><kwd>kidney tubules</kwd><kwd>ultrastructure</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Добронравов ВА, Голубев РВ и др. Рас пространенность гипергомоцистеинемии в зависимости от стадии хронической болезни почек. Нефрология 2005; 9(2): 4852</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Добронравов ВА, Голубев РВ и др. Рас пространенность гипергомоцистеинемии в зависимости от стадии хронической болезни почек. Нефрология 2005; 9(2): 4852</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Arnadottir M, Hultberg B, NilssonEhle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996; 56 (1): 4146</mixed-citation><mixed-citation xml:lang="en">Arnadottir M, Hultberg B, NilssonEhle P, Thysell H. The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 1996; 56 (1): 4146</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to GFR in diabetes mellitus. Kidney Int 1999; 55 (3): 10281032</mixed-citation><mixed-citation xml:lang="en">Wollesen F, Brattstrom L, Refsum H, et al. Plasma total homocysteine and cysteine in relation to GFR in diabetes mellitus. Kidney Int 1999; 55 (3): 10281032</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Jakubowski H. Protein homocysieintlation: possible mechanism underlying pathological consequences of elevated homocystein level. The FASEB Journal 1999; 13: 22772283</mixed-citation><mixed-citation xml:lang="en">Jakubowski H. Protein homocysieintlation: possible mechanism underlying pathological consequences of elevated homocystein level. The FASEB Journal 1999; 13: 22772283</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">van Guldener C, Kulik W, Berger R et al. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int 1999; 56 (3): 10641071</mixed-citation><mixed-citation xml:lang="en">van Guldener C, Kulik W, Berger R et al. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int 1999; 56 (3): 10641071</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40(4): 230 235</mixed-citation><mixed-citation xml:lang="en">Hultberg B, Andersson A, Sterner G. Plasma homocysteine in renal failure. Clin Nephrol 1993; 40(4): 230 235</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">van Guldener C, Janssen MJFM, de Meer K et al. CDA Effect of folic acid and betaine on fasting and postmethionine loading plasma homocysteine and methionine levels in chronic hemodialysis patients. J Int Med 1999; 245: 175183</mixed-citation><mixed-citation xml:lang="en">van Guldener C, Janssen MJFM, de Meer K et al. CDA Effect of folic acid and betaine on fasting and postmethionine loading plasma homocysteine and methionine levels in chronic hemodialysis patients. J Int Med 1999; 245: 175183</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Cook JW, Taylor LM, Orloff SL et al. Homocysteine and arterial disease. Experimental mechanisms. Vascul Pharmacol 2002; 38(5): 293300</mixed-citation><mixed-citation xml:lang="en">Cook JW, Taylor LM, Orloff SL et al. Homocysteine and arterial disease. Experimental mechanisms. Vascul Pharmacol 2002; 38(5): 293300</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Kim JM, Lee H, Chang N. Hyperhomocysteinemia due to shortterm folate deprivation is related to electron microscopic changes in the rat brain. J Nutr 2002;132(11): 34183421</mixed-citation><mixed-citation xml:lang="en">Kim JM, Lee H, Chang N. Hyperhomocysteinemia due to shortterm folate deprivation is related to electron microscopic changes in the rat brain. J Nutr 2002;132(11): 34183421</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Baumbach GL, Sigmund CD, Bottiglieri T, Lentz SR. Structure of cerebral arterioles in cystathionine betasynthase deficient mice. Circ Res 2002; 91(10):931937</mixed-citation><mixed-citation xml:lang="en">Baumbach GL, Sigmund CD, Bottiglieri T, Lentz SR. Structure of cerebral arterioles in cystathionine betasynthase deficient mice. Circ Res 2002; 91(10):931937</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Rolland PH, Friggi A, Barlatier A et al. Hyperhomocysteinemiainduced vascular damage in the minipig: captoprilhydrochlorothiazide combination prevents elastic alterations. Circulation 1995; 91: 1161–1174</mixed-citation><mixed-citation xml:lang="en">Rolland PH, Friggi A, Barlatier A et al. Hyperhomocysteinemiainduced vascular damage in the minipig: captoprilhydrochlorothiazide combination prevents elastic alterations. Circulation 1995; 91: 1161–1174</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Miller A, Mujumdar V, Shek E et al. Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels 2000;15(3):135143</mixed-citation><mixed-citation xml:lang="en">Miller A, Mujumdar V, Shek E et al. Hyperhomocyst(e)inemia induces multiorgan damage. Heart Vessels 2000;15(3):135143</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 2002; 39 (2 Pt 2): 443448</mixed-citation><mixed-citation xml:lang="en">Li N, Chen YF, Zou AP. Implications of hyperhomocysteinemia in glomerular sclerosis in hypertension. Hypertension 2002; 39 (2 Pt 2): 443448</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chen YF, Li PL, Zou AP. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation 2002;106:12751281</mixed-citation><mixed-citation xml:lang="en">Chen YF, Li PL, Zou AP. Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation 2002;106:12751281</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Смирнов АВ, Добронравов ВА, Неворотин АИ и др. Гомоцистеин вызывает повреждения не только клубочково го, но и канальцевого отдела нефрона (экспериментальное исследование) Нефрология 2005; 9(3): 8187</mixed-citation><mixed-citation xml:lang="en">Смирнов АВ, Добронравов ВА, Неворотин АИ и др. Гомоцистеин вызывает повреждения не только клубочково го, но и канальцевого отдела нефрона (экспериментальное исследование) Нефрология 2005; 9(3): 8187</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Ormrod D, Miller T. Experimental uremia. Description of a model producing varying degrees of stable uremia. Nephron 1980; 26(5): 249254</mixed-citation><mixed-citation xml:lang="en">Ormrod D, Miller T. Experimental uremia. Description of a model producing varying degrees of stable uremia. Nephron 1980; 26(5): 249254</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Anderson S, Brenner B. The role of intraglomerular pressure in the initiation and progression of renal disease. J Hypertens Suppl 1986; 4(5): S2368</mixed-citation><mixed-citation xml:lang="en">Anderson S, Brenner B. The role of intraglomerular pressure in the initiation and progression of renal disease. J Hypertens Suppl 1986; 4(5): S2368</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Schwartz MM, Bidani AK, Lewis EJ. Glomerular epithelial cell function and pathology following extreme ablation of renal mass. Am J Pathol 1987;126(2):31524</mixed-citation><mixed-citation xml:lang="en">Schwartz MM, Bidani AK, Lewis EJ. Glomerular epithelial cell function and pathology following extreme ablation of renal mass. Am J Pathol 1987;126(2):31524</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Olson JL, de Urdaneta AG, Heptinstall RH. Glomerular hyalinosis and its relation to hyperfiltration. Lab Invest 1985; 52(4): 38798</mixed-citation><mixed-citation xml:lang="en">Olson JL, de Urdaneta AG, Heptinstall RH. Glomerular hyalinosis and its relation to hyperfiltration. Lab Invest 1985; 52(4): 38798</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zhloba AA, Blashko EL. Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 800 (12): 275280</mixed-citation><mixed-citation xml:lang="en">Zhloba AA, Blashko EL. Liquid chromatographic determination of total homocysteine in blood plasma with photometric detection. J Chromatogr B Analyt Technol Biomed Life Sci 2004; 800 (12): 275280</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Burns MW, Alpers CE et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 42: 297309</mixed-citation><mixed-citation xml:lang="en">Floege J, Burns MW, Alpers CE et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 42: 297309</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Ohashi R, Nakagawa T, Watanabe S et al. Inhibition of p38 mitogenactivated protein kinase augments progression of remnant kidney model by activating the ERK pathway. Am J Pathol 2004;164(2): 477485</mixed-citation><mixed-citation xml:lang="en">Ohashi R, Nakagawa T, Watanabe S et al. Inhibition of p38 mitogenactivated protein kinase augments progression of remnant kidney model by activating the ERK pathway. Am J Pathol 2004;164(2): 477485</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Feng L, Xia Y, Yoshimura T, Wilson CB. Modulation of neutrophil influx in glomerulonephritis in the rat with anti macrophage inflammatory protein2 (MIP2) antibody. J Clin Invest 1995; 95(3):100917</mixed-citation><mixed-citation xml:lang="en">Feng L, Xia Y, Yoshimura T, Wilson CB. Modulation of neutrophil influx in glomerulonephritis in the rat with anti macrophage inflammatory protein2 (MIP2) antibody. J Clin Invest 1995; 95(3):100917</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002;186:818</mixed-citation><mixed-citation xml:lang="en">Ley K. Integration of inflammatory signals by rolling neutrophils. Immunol Rev 2002;186:818</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Alon R, Feigelson S. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at subsecond contacts. Semin Immunol 2002;14(2): 93104</mixed-citation><mixed-citation xml:lang="en">Alon R, Feigelson S. From rolling to arrest on blood vessels: leukocyte tap dancing on endothelial integrin ligands and chemokines at subsecond contacts. Semin Immunol 2002;14(2): 93104</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Alpers CE, Burns MW et al. Glomerular cells, extracellular matrix accumulation, and development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66(4):48597</mixed-citation><mixed-citation xml:lang="en">Floege J, Alpers CE, Burns MW et al. Glomerular cells, extracellular matrix accumulation, and development of glomerulosclerosis in the remnant kidney model. Lab Invest 1992; 66(4):48597</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Burns MW, Alpers CE et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 4(2):297309</mixed-citation><mixed-citation xml:lang="en">Floege J, Burns MW, Alpers CE et al. Glomerular cell proliferation and PDGF expression precede glomerulosclerosis in the remnant kidney model. Kidney Int 1992; 4(2):297309</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Floege J, Lonson RJ, Couser WG. Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin Invest 1992; 70(9): 857913</mixed-citation><mixed-citation xml:lang="en">Floege J, Lonson RJ, Couser WG. Mesangial cells in the pathogenesis of progressive glomerular disease in animal models. Clin Invest 1992; 70(9): 857913</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Shankland SJ, Hamel P, Scholey JW. Cyclin and cyclin dependent kinase expression in remnant glomerulus J Am Soc Nephrol 1997; 8(3): 368375</mixed-citation><mixed-citation xml:lang="en">Shankland SJ, Hamel P, Scholey JW. Cyclin and cyclin dependent kinase expression in remnant glomerulus J Am Soc Nephrol 1997; 8(3): 368375</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Caglar Y, Kaya M, Belge E, Mete UO. Ultrastructural evaluation of the effect of endosulfan on mice kidney. Histol Histopathol 2003;18(3):703708</mixed-citation><mixed-citation xml:lang="en">Caglar Y, Kaya M, Belge E, Mete UO. Ultrastructural evaluation of the effect of endosulfan on mice kidney. Histol Histopathol 2003;18(3):703708</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">Obineche EN, MensahBrown E, Chandranath SI et al. Morphological changes in the rat kidney following longterm diabetes. Arch Physiol Biochem 2001;109(3): 241245</mixed-citation><mixed-citation xml:lang="en">Obineche EN, MensahBrown E, Chandranath SI et al. Morphological changes in the rat kidney following longterm diabetes. Arch Physiol Biochem 2001;109(3): 241245</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Bal C, Longkumer T, Patel C et al. Renal function and structure in subacute hepatic failure. J Gastroenterol Hepatol 2000;15(11): 13181324</mixed-citation><mixed-citation xml:lang="en">Bal C, Longkumer T, Patel C et al. Renal function and structure in subacute hepatic failure. J Gastroenterol Hepatol 2000;15(11): 13181324</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Ono T, Liu N, Makino T et al. Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis. J Pathol 2004; 204(2): 229238</mixed-citation><mixed-citation xml:lang="en">Ono T, Liu N, Makino T et al. Role of mesangial Factor V expression in crescent formation in rat experimental mesangioproliferative glomerulonephritis. J Pathol 2004; 204(2): 229238</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Davin JC, Dechenne C, Lombet J et al. Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgAconcanavalin A complexes. Virchows Arch A Pathol Anat Histopathol 1989; 415(1): 720</mixed-citation><mixed-citation xml:lang="en">Davin JC, Dechenne C, Lombet J et al. Acute experimental glomerulonephritis induced by the glomerular deposition of circulating polymeric IgAconcanavalin A complexes. Virchows Arch A Pathol Anat Histopathol 1989; 415(1): 720</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">D’Agati V, Chander P, Nash M, MancillaJimenez R. Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 1986; 7(1): 95110</mixed-citation><mixed-citation xml:lang="en">D’Agati V, Chander P, Nash M, MancillaJimenez R. Idiopathic microscopic polyarteritis nodosa: ultrastructural observations on the renal vascular and glomerular lesions. Am J Kidney Dis 1986; 7(1): 95110</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Coppola A, Davi G, De Stefano V et al. Homocysteine, coagulation, platelet fuction and thrombosis. Semin Thromb Hemost 2000; 26(3): 243254</mixed-citation><mixed-citation xml:lang="en">Coppola A, Davi G, De Stefano V et al. Homocysteine, coagulation, platelet fuction and thrombosis. Semin Thromb Hemost 2000; 26(3): 243254</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ay H, Arsava EM, Tokgozoglu SL et al. Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation. Stroke 2003; 34(4): 909912</mixed-citation><mixed-citation xml:lang="en">Ay H, Arsava EM, Tokgozoglu SL et al. Hyperhomocysteinemia is associated with the presence of left atrial thrombus in stroke patients with nonvalvular atrial fibrillation. Stroke 2003; 34(4): 909912</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Heil SG, De Vriese AS, Kluijtmans LA et al. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)mediated vasodilatation. Cell Mol Biol (Noisylegrand) 2004; 50 (8): 911916</mixed-citation><mixed-citation xml:lang="en">Heil SG, De Vriese AS, Kluijtmans LA et al. The role of hyperhomocysteinemia in nitric oxide (NO) and endothelium derived hyperpolarizing factor (EDHF)mediated vasodilatation. Cell Mol Biol (Noisylegrand) 2004; 50 (8): 911916</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Nevorotin AI. Endoplasmic reticulum (a review of the literature). Tsitologiia 1992; 34(8): 325</mixed-citation><mixed-citation xml:lang="en">Nevorotin AI. Endoplasmic reticulum (a review of the literature). Tsitologiia 1992; 34(8): 325</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Pow DV, Morris JF, Rodgers S. Peptide accretions in the endoplasmic reticulum of magnocellular neurosecretory neurons in normal and experimentally manipulated rats. J Anat 1991; 178: 155174</mixed-citation><mixed-citation xml:lang="en">Pow DV, Morris JF, Rodgers S. Peptide accretions in the endoplasmic reticulum of magnocellular neurosecretory neurons in normal and experimentally manipulated rats. J Anat 1991; 178: 155174</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Hutchinson S, Aplin RT, Webb H et al. Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuria. J Mol Biol 2005; 346(3): 833 844</mixed-citation><mixed-citation xml:lang="en">Hutchinson S, Aplin RT, Webb H et al. Molecular effects of homocysteine on cbEGF domain structure: insights into the pathogenesis of homocystinuria. J Mol Biol 2005; 346(3): 833 844</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Werstuck GH, Lentz SR, Dayal S et al. Homocysteine induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107(10):12631273</mixed-citation><mixed-citation xml:lang="en">Werstuck GH, Lentz SR, Dayal S et al. Homocysteine induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J Clin Invest 2001;107(10):12631273</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003; 7(4):255259</mixed-citation><mixed-citation xml:lang="en">Asanuma K, Mundel P. The role of podocytes in glomerular pathobiology. Clin Exp Nephrol 2003; 7(4):255259</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83(1): 253307</mixed-citation><mixed-citation xml:lang="en">Pavenstadt H, Kriz W, Kretzler M. Cell biology of the glomerular podocyte. Physiol Rev 2003; 83(1): 253307</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Hultberg B. Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport. Clin Chem Lab Med 2004; 42(4): 378383</mixed-citation><mixed-citation xml:lang="en">Hultberg B. Extracellular concentration of homocysteine in human cell lines is influenced by specific inhibitors of cyst(e)ine transport. Clin Chem Lab Med 2004; 42(4): 378383</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Kumagai H, Katoh S, Hirosawa K et al. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int 2002; 62(4):12191228</mixed-citation><mixed-citation xml:lang="en">Kumagai H, Katoh S, Hirosawa K et al. Renal tubulointerstitial injury in weanling rats with hyperhomocysteinemia. Kidney Int 2002; 62(4):12191228</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Chang L, Xu J, Yu F et al. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 2004; 27(1):3748</mixed-citation><mixed-citation xml:lang="en">Chang L, Xu J, Yu F et al. Taurine protected myocardial mitochondria injury induced by hyperhomocysteinemia in rats. Amino Acids 2004; 27(1):3748</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Harrington EO, Newton J, Morin N, Rounds S. Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 2004; 287(6): L10911097</mixed-citation><mixed-citation xml:lang="en">Harrington EO, Newton J, Morin N, Rounds S. Barrier dysfunction and RhoA activation are blunted by homocysteine and adenosine in pulmonary endothelium. Am J Physiol Lung Cell Mol Physiol 2004; 287(6): L10911097</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
